Search results
Results from the WOW.Com Content Network
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales.
The Food and Drug Administration (FDA) of the Philippines, formerly the Bureau of Food and Drugs (BFAD / ˈ b iː f æ d /; 1982–2009), is a health regulatory agency under the Department of Health created on 1963 by Republic Act No. 3720, amended on 1987 by Executive Order 175 otherwise known as the "Food, Drugs and Devices, and Cosmetics Act", and subsequently reorganized by Republic Act No ...
In the US, where a system of quasi-private healthcare is in place, a formulary is a list of prescription drugs available to enrollees, and a tiered formulary provides financial incentives for patients to select lower-cost drugs. For example, under a 3-tier formulary, the first tier typically includes generic drugs with the lowest cost sharing ...
The DOH is composed of bureaus, services & program offices, under the following clusters: Office of the Secretary – Proper (OSEC) 1. Philippine Health Insurance Corporation (PhilHealth); 2. Food and Drug Administration (FDA); 3. Philippine National Aids Council (PNAC); 4. GOCC Hospitals, including: Philippine Children’s Medical Center (PCMC);
A national formulary is essentially a listing of available and affordable medicines that are relevant to the treatment of diseases in a particular country. It is usually a source of unbiased drug information and helps promote the rational use of safe, effective and good-quality medicines.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Under an integrated national pharmaceutical policy, the central buying agency channels all imports and production of pharmaceuticals, calling for worldwide bulk tenders which are limited to the approved drugs listed in the national formulary. The public and private health sectors must obtain all their requirements from the central buying agency.
The Dangerous Drugs Board was established on November 14, 1972 with seven national agencies as its initial component members – the Department of Health; Department of Education, Culture and Sports; Department of Justice, Department of National Defense, Department of Finance, and the National Bureau of Investigation. [2]